HALO: Halozyme Therapeutics, Inc. Stock

by  •  • Comments Off on HALO: Halozyme Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 7,112.09
Enterprise Value ($M) 8,502.03
Book Value ($M) 363.82
Book Value / Share 2.95
Price / Book 19.55
NCAV ($M) -614.32
NCAV / Share -4.99
Price / NCAV -11.58

Profitability (mra)
Return on Invested Capital (ROIC) 0.23
Return on Assets (ROA) 0.26
Return on Equity (ROE) 5.30

Liquidity (mrq)
Quick Ratio 6.78
Current Ratio 7.80

Balance Sheet (mrq) ($M)
Current Assets 1,085.34
Assets 2,063.48
Liabilities 1,699.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,015.32
Operating Income 551.48
Net Income 444.09
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 479.06
Cash from Investing -262.72
Cash from Financing -218.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Artisan Partners Limited Partnership 2.50 -53.16
10-17 13G State Street Corp 5.20
2024-02-13 13G/A Vanguard Group Inc 10.04 -1.99
2024-02-01 13G/A Invesco Ltd. 2.10 -59.98

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 342,897 1,067,149 32.13
2025-02-21 319,988 991,293 32.28
2025-02-20 278,385 1,207,883 23.05
2025-02-19 475,039 1,945,107 24.42

(click for more detail)

Similar Companies
GILD – Gilead Sciences, Inc. GLUE – Monte Rosa Therapeutics, Inc.
GOSS – Gossamer Bio, Inc. HLVX – HilleVax, Inc.
HOWL – Werewolf Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io